Ascendis Pharma A/S Announces U.S. Food and Drug Administration Approval of SKYTROFA® (lonapegsomatropin-tcgd), the First Once-weekly Treatment for Pediatric Growth Hormone Deficiency
– SKYTROFA, the first FDA approved treatment utilizing TransConâ„¢ technology, is a long-acting prodrug of…